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Potentiation ofHepatic and Renal
ToxicityofVarious Compounds by Prior
Exposureto Polybrominated Biphenyls
byW. M. Kluwe,* K. M. McCormack,* and J. B. Hook*
Mice ingesting a standard rodent diet supplemented with polybrominated biphenyls (PBBs) were more
susceptible to chlorinated hydrocarbon solvent-induced renal and hepatic damage, as weU as the lethal
effects ofCHCI3 and CC14, than were mice consuming control diet. As little as0.025ml/kg CHCI3caused a
significant increase in serum glutamic oxaloacetic transaminase (SGOT) and blood urea nitrogen (BUN)
and a significant decrease in renal cortical slices accumulation of p-aminohippurate (PAH) in PBB-
pretreated but not control mice. SGOT and serum glutamic pyruvate transaminase (SGPT) were greater
inPBB-pretreated mice than incontrol miceafter 0.125 and 0.005 ml/kgCC14, respectively. Renalcortical
PAH accumulation was greatly reduced in PBB-pretreated but not control mice after 0.125 ml/kg CC14.
The solvent-induced decrease in PAH accumulation was also greater in PBB-pretreated mice than in
control mice following administration of 1.0 ml/kg trichloroethylene (TRI) and 0.15 ml/kg 1,1,2-
trichloroethane (TCE).
Introduction
Much effort has been expended in studying the
toxicology of halogenated aromatic hydrocarbons.
Characteristically, these compounds are persistent
environmental pollutants which can become
contaminants of foodstuffs and be ingested by hu-
mans or domestic animals through the diet. Once
ingested, such chemicals have long tissue half-lives
because of their highly lipophilic nature. One such
class of chemicals, the polybrominated biphenyls
(PBBs), were developed as fire retardants but were
accidentally mixed into animal feed resulting in
heavy exposure ofdomestic farm animals to dietary
PBBs. Secondary exposure of humans to PBBs oc-
curred from ingestion of meat and dairy products
derived from contaminated livestock (1). As can be
seen from the other studies presented at this confer-
ence, several abnormalities have been induced by
exposure of animals to high doses of PBBs. The
toxicological significance of chronic, low-level, di-
etary PBB exposure, though, has not been
thoroughlyevaluated.
One of the most striking features of PBB expo-
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sure is the resultant hepatic hypertrophy and greatly
increased activities of microsomal mixed function
oxygenases (MFO) (2). Increased MFO activities
after PBB administration can be demonstrated in
the kidney as well as the liver (3). Though com-
monly regarded as the functional mediators of
xenobiotic metabolism, MFOs can be instrumental
in toxification as well as detoxification processes (4,
5). For example, it has been proposed that many of
the small, aliphatic, halogenated hydrocarbon sol-
vents are dependent upon biotransformation for
manifestation of hepatic and renal injury. Studies
involving use ofin vitro activation techniques have
suggested that microsomal enzymes are necessary
for generation of the toxic metabolites of solvents
such as chloroform (CHC13) (6), carbon tet-
rachloride (CCI4) (7), trichloroethylene (8), and
1,1,2-trichloroethane (TCE) (9). Thus, it was of
interest to determine the effects of PBB-induced
stimulation of microsomal enzymes on the toxicity
of several chlorinated aliphatic hydrocarbon sol-
vents.
Methods
Adult, male, ICR mice (20-30 g) were housed in
groups of six in clear plastic shoe-box type cages in
a well-ventilated, light-cycle controlled room
April 1978 241maintained at 22+1°C and allowed food and water
adlibitum.
Treatments
Polybrominated biphenyls (PBBs as FireMaster
BP-6) were dissolved in acetone and mixed slowly
and evenly into finely ground Wayne Lablox to
produce final concentrations of 0, 1, 20, 25, or 100
ppm PBB. The mice were maintained on control
(0 ppm PBB) or PBB-supplemented diets for 14-28
days before a single IP injection of one of several
doses of chloroform (CHCl3), carbon tetrachloride
(CCI4), trichloroethylene (TRI) or 1,1,2-
trichloroethane (TCE). All solvents were dissolved
in corn oil and injected in a total volume of5 ml/kg.
The mice were sacrificed 24 hr (CHCl3, TRI, TCE)
or 48 hr (CCl4) after solvent injection by decapita-
tion. Blood was collected in disposable glass tubes.
Livers and kidneys were quickly but carefully ex-
cised, cleaned of extraneous tissue, and weighed.
Thinslicesofrenalcortexwerecutfree-hand.
SerumAssays
Whole blood was allowed to clot for 1-2 hr and
carefully centrifuged. Serum was drawn offand re-
frigerated till the time ofassay. Blood urea nitrogen
(BUN) was determined by use of Sigma reagents
(Sigma Chemical Co., St. Louis, Mo.) and serum
glutamic oxaloacetic transaminase (SGOT) and
serum glutamic pyruvic transaminase (SGPT) by
themethodofReitmanandFrankel(10).
PAHSIMRatio
Thin renal cortical slices were incubated in a
phosphate-buffered medium (11) containing 2.5 x
10-5M p-aminohippurate (PAH) and 1 x 10-2M
acetate for 90 min at 25°C under an atmosphere of
100% 02. Slices were then blotted, weighed, and
homogenized in 10% trichloroacetic acid. An
aliquot ofmedium was treated in the same manner.
The precipitated protein was pelleted by centrifu-
gation and samples of the supernatant fraction
acidified with 0.25 volumes of IN HCl and placed in
a boiling water bath for 1 hr to hydrolyze any
acetylated PAH. PAH was determined by the
method of Smith et al. (12). Accumulation of PAH
was represented as the slice-to-medium ratio (SIM)
where S is in units ofmg PAH/g tissue and M is mg
PAH/ml medium. The percent decrease in PAH ac-
cumulation was determined by using the formula
(13):
%Decrease = (ControlSIM) - (TreatedSIM)
(ControlSIM)- 1
LD50Determinations
Mice were maintained on 0 or 100 ppm PBB-
supplemented diets for 14 days prior to a single IP
injection of various doses of CHC13, dissolved in
corn oil, in a total volume of5 ml/kg. Anothergroup
ofmice were maintained on 0, 20, or 100 ppm PBB-
supplemented diets for 20 days prior to a single IP
injection ofvarious doses ofCC14, dissolved in corn
oil, in a total volume of 5 mi/kg. The number of
deaths occurring within 24, 48, 96, and 168 hr were
recorded. The LD50 was calculated according to the
methodsofLitchfieldandWilcoxin(14).
Statistics
Data were analyzed by analysis of variance, ran-
domized complete block design, and treatment
means compared using the least significant differ-
ence (LSD) test (15) withp < 0.05 as the criterion of
significance.
Results
The liver weight-to-body weight ratio (LW/BW)
was increased in mice consuming dietary PBBs
(Tables 1-4) The increase in LW/BW was propor-
tional to the concentration ofPBB in the diet (Table
1) and to the duration ofPBB feeding. The LW/BW
after 14 days on 100 ppm PBBs was 162% ofcontrol
(Table 1) and 230% of control after 28 days on 100
ppm PBBs (Table 3). Since weight differences be-
tween control and treated mice were not significant
(data not shown), it would appear that increased
LW/BW was due to liverhypertrophy. No elevation
of serum glutamic oxaloacetic transaminase
(SGOT) was evident in control mice following doses
of CHCl3 of up to 50 /u4kg, suggesting that these
were subhepatotoxic doses ofCHCl3 in normal mice
(Table 1). Mice ingesting 100 ppm PBBs exhibited a
slight rise in SGOT. As the dose of CHCl3 was in-
creased, however, SGOT continued to rise
suggesting that these doses of CHCl3 (25 and 50
,4/kg) were toxic to the liver in mice consuming 100
ppmPBBs(Table 1).
The kidney weight-to-body weight ratio
(KW/BW) was not affected by dietary PBBs nor by
CHCl3 administration in doses up to50,u4/kg in mice
consuming 0 ppm PBB (Table 2). Mice ingesting
PBB-supplemented diets, however, responded to 50
/l/kg CHC13 with increased KW/BW (Table 2).
Since body weights were not affected by dietary
PBB, it appeared that PBB enhanced the renal tox-
icityofCHC13.
Blood urea nitrogen concentrations (BUN) were
similarly unaffected by dietary PBB or CHCl3 ad-
Environmental Health Perspectives 242Table 1. Effect of PBB and CHC13 on mouse liver weight-to-body weight ratio (LW/BW) and serum glutamic oxaloacetic transaminase
activity (SGOT).a
PBB, CHC13,u/kg
Parameter ppm 0 2.5 5.0 25.0 50.0
LW/BW x 100 0 5.97 ±0.23 5.93 ±0.30 6.47 0.40 6.09 0.19 6.39 0.13
1 6.10 0.19 6.17 0.10 6.11 ±0.13 5.61 ±0.15 6.01 ±0.17
25 6.91 +0.3lb 7.36 0.19 6.76 0.12 7.35 0.12b 6.46 0.12
100 9.68 ± 0.38b 9.74 ± 0.30b 9.64 0.25b 10.14 0.34b 9.54 ± 0.23b
SGOT, U/ml 0 242 ±40 250 62 311 ±48 226 27 267 ±81
1 285 63 322 41 334 23 403 62 412 ± 94
25 173 21 148±46 196±39 232±27 308±61
100 385 +27b 512 39b 529 92b 1274 ± 283b,c 1340 ± 306b.c
a Mice were maintained on 0, 1, 25, or 100 ppm PBB-supplemented diets for 14 days prior to a single IP injection of0, 2.5, 5.0, 25.0, or
50.0 u./kg CHC13. LW/BW and SGOT were determined 24 hr after administration of CHC13. Data are represented as means + I
standarderrorofsixanimals.
b Significantincrease incomparison tomicereceivingthe samedoseofCHCI3butingesting0ppmPBB.
c Significant increase incomparison tomiceingestingthe samedietaryconcentration ofPBB butreceiving0.0,AlkgCHC13.
Table 2. Effect ofPBB and CHC13 on mouse kidney weight-to-body weight ratio (KW/BW), blood urea nitrogen (BUN) concentration, and
p-aniinohippurateaccumulation(PAHS/M).a
PBB, CHC13,illkg
Parameter ppm 0 2.5 5.0 25.0 50.0
KW/BW x 100 0 1.54 0.05 1.64 ±0.08 1.68 0.05 1.63 ± 0.08 1.70 ± 0.10
1 1.49 0.04 1.54 0.04 1.47 0.04 1.46 ± 0.08 1.98 ± 0.07b.c
25 1.47 ± 0.03 1.55 ± 0.03 1.46 0.05 1.76 ± 0.03 2.12 ± 0.04b.c
100 1.58 ± 0.04 1.37 ± 0.04 1.42 ± 0.06 1.70 ± 0.19 2.21 ± o.09bc
BUN,mg% 0 21 1.3 23 1.6 27 3.7 26 ± 2.6 28 ± 3.1
1 22±3.6 21 2.2 23± 4.1 35± 3.8 43± 3.6
25 22 2.0 24 1.8 21 2.0 47± 49b.c 84 ± 6.2b.c
100 21 ± 1.8 22 ± 2.6 28 ± 2.0 81 9.3b.c 108 ± Io.b.c
Decrease 0 - 1.8 ±0.9 2.7 ± 3.6 22.1 ±13.3 63.8± 18.2
inPAHS/M,% 1 0.4 ±0.3 2.9 ± 1.2 22.6 ± 11.2 53.6 ± 14.2b.c 58.5+ 16.22b.c
25 0.0 3.6 ±1.7 30.1 ± 19.3 42.8 18.2b.c 78.1 23.7b.c
100 0.0 34.6 7.8b 35.0 10.9b.c 49.3 ± 17.5b.c 38.2 14.6b,C
a Mice were maintained on 0, 1, 25, or 100 ppm PBB-supplemented diets for 14 days prior to a single IP injection of0, 2.5, 5.0, 25.0,
or 50.0 ,u/kg CHC13. KW/BW, BUN, and PAH SIM were deterniined 24 hr after administration of CHCI3. Data are represented as
means ± 1 standard errorofsixanimals.
b Significantincrease incomparisontomicereceivingthe samedoseofCHC13butingesting0ppmPBBs.
c Significantincrease incomparison tomiceingestingthe samedietaryconcentration ofPBBsbutreceiving0.0IL/kgCHC13.
ministration in control mice (Table 2). Significant
increases were evident, though, in mice ingesting 25
or 100 ppm PBB after 25 or 50 ,1/kg CHC13 (Table
2).
A significant depression in accumulation of the
organic anion p-aminohippurate (PAH) by renal
cortical slices from control mice was evident only
after administration of 50 gldkg CHCl3 (Table 2).
Significant depressions were evident after 25 IA/kg
CHC13 in mice consuming 1 or 25 ppm PBB, and
after as little as 2.5 ,I/kg CHC13 in mice consuming
100ppmPBB(Table2).
LW/BW was increased in control mice 48 hr after
injection of 0.125 and 0.625 ml/kg CC14 (Table 3),
indicating hepatic damage at these doses. Similar
increases were not evident in mice on 100 ppm PBB
though livers were already more than double normal
size(Table3).
SGOT and serum glutamic pyruvic transaminase
(SGPT) were elevated by 0.125 and 0.625 ml/kg
CCl4 in control mice (Table 3). A significant rise in
SGOT was evident also in mice ingesting 100 ppm
PBB following administration of 0.125 mI/kg CCI4.
The increase in the PBB-pretreated mice was
greaterthan the increase in control mice. SGPT was
elevated slightly by PBB ingestion (Table 3). A sig-
nificant increase in SGPT was evident after 0.005
ml/kg CCl4 in comparison to vehicle in mice ingest-
ing 100 ppm PBB (Table 3) suggesting that PBB-
pretreatment "sensitized" mice to the relative
April 1978 243Table 3. Effect of PBB and CCl4 on liver and kidney weight-to-body weight ratios (LW/BW, KW/BW), serum glutamic oxaloacetic and
pyruvictransaminases (SGOT, SGPT),bloodureanitrogen(BUN),andp-aminohippurateaccumulation(PAHS/MV'
PBB, CC14,ml/kg
Parameter ppm 0.0 0.005 0.025 0.125 0.625
LW/BW x 100 0 5.93 ± 0.10 5.74 ± 0.17 5.77 ± 0.10 6.54 ± 0.20b 7.51 ± 0.10b
100 13.62 ± 0.35c 13.10 ± 0.95c 13.10 ± 0.50c 13.13 0.40c Expired
SGOT,U/ml 0 56.3 ± 7.6 41.3 ± 4.9 65.0 ± 4.9 147.5 ± 23.3" 301.2 + 50.2b
100 54.5 ± 7.7 57.8 ± 6.2 70.7 ± 9.8 384.5 ± 36.2l.c Expired
SGPT,U/ml 0 26.8 ± 3.0 24.0 ± 3.4 29.2 ± 4.1 133.8 6.8" 205.2 ± 12.0b
100 45.0 ± 5.7c 93.0 ± 17.8b.c 126.7 ± 23.lb.c 199.7 16.6b.c Expired
KW/BW x 100 0 1.51 ± 0.03 1.49 ± 0.03 1.60 ± 0.01 1.46 ± 0.01 1.95 ± 0.20b
100 1.42 ± 0.02 1.45 ± 0.04 1.45 ± 0.03 1.46 ± 0.04 Expired
BUN,mgo 0 11.4 ± 1.8 12.0 ± 1.3 11.8 ± 1.2 10.6 ± 1.2 20.2± 1.8
100 13.5 ± 1.7 14.0 ± 1.4 14.3 ± 1.7 18.5 ± 1.6 Expired
Decrease 0 - 0.1 ± 0.2 2.9 ± 1.8 31.2 ± 19.7
inPAHS/M,% 100 0.6 ± 0.3 3.7 ± 2.6 13.1 ± 8.2 74.0 t 26.8b.c Expired
a Mice were maintained on diet supplemented with 0 or 100 ppm PBB for 28 days prior to a single IP injection of0.000, 0.005, 0.025,
0.125, or 0.625 ml/kg CC14. All parameters were measured 48 hr after administration of CC14. Data are represented as means ± 1
standarderrorofsixanimals.
b Significantincreaseincomparisontomiceingestingthesamedietaryconcentration ofPBB butreceiving0.000mi/kgCC14.
c Significantincrease incomparisontomicereceivingthe samedoseofCC14butingesting0ppmPBB.
Table 4. Effect of PBB, TRI, and TCE on mouse liver and kidney weight-to-body weight ratios (LW/BW, KW/BW), serum glutamic
oxaloaceticandpyruvictransaminases(SGOT,SGPT)bloodureanitrogen(BUN)andp-aminohippurateaccumulation(PAHS/M)W'
PBB, Control TRI, TRI, TCE,
Parameter ppm 0.0 0.5mi/kg 1.0ml/kg 0.15mi/kg
LW/BW x 100 0 6.16 0.04 5.80 0.22 5.71 ± 0.10 6.49 0.20
100 9.61 ± 0.05b 9.53 ± 0.14b 9.42 ± 0.28b 9.52 ± 0.45b
SGOT,U/ml 0 37.2 4.1 50.8 3.6 55.3 6.6 40.7 2.8
100 42.7 ± 3.8 44.3 ± 2.4 62.3 ± 9.2 50.2 ± 3.7
KW/BWx 100 0 1.55±0.04 1.64±0.03 1.56±0.04 1.54±0.05
100 1.53 0.02 1.63 0.03 1.52 0.05 1.51 0.04
BUN,mg% 0 15.6 1.8 17.4 1.4 18.6 1.4 15.1 1.3
100 16.5 ± 1.3 16.5 ± 1.0 19.1 ± 2.3 14.8 ± 1.4
Decrease 0 20.0 4.lc 24.7 _2.2c 22.3 _2.6c
inPAHS/M, % 100 0.0 26.3 ± 2.6" 44.0± 6.3b.c 39.2 ± 4.3b.c
a Mice were maintained on diet supplemented with 0 or 100 ppm PBB for 14 days prior to a single IP injection ofvehicle (0.0), 0.5 or
1.0 ml/kg trichloroethylene (TRI), or 0.15 mi/kg 1,1,2-trichloroethane (TCE). All parameters were measured 24 hr after administration
ofTRIorTCE. Dataarerepresentedasmeans ± 1 standarderrorofsixdeterminations.
b Significantincreaseincomparisontomicereceivingthe samedoseofsolventbutingesting0ppmPBB.
c Significant increase incomparisontomiceingestingthe samedietaryconcentration ofPBBbutreceivingonlyvehicle.
hepatotoxic effects ofCCl4. CCI4 at a level of0.625
mi/kg produced death in all PBB-pretreated mice
but was not lethal to any ofthe control mice (Table
3).
KW/BW was elevated 48 hr after 0.625 ml/kg
CC14 in control mice (Table 3). This dose was lethal
to PBB-pretreated mice. Lower doses were without
effectonKW/BW.
BUN concentrations were not elevated by CC14
administration in mice consuming 0 or 100 ppm PBB
(Table 3). Though the PAH SIM was reduced by
more than 30o following administration of 0.625
mi/kg CCI4 to control mice (Table 3), the depression
was not statistically significant. A significant de-
pression was observed, though, following 0.125
ml/kg CCI4 in mice ingesting 100 ppm PBB (Ta-
ble 3), suggesting that the renal toxicity ofCCl4 was
enhancedbypretreatmentwithPBB.
LW/BW was not elevated by administration of
trichloroethylene (TRI) or 1,1,2-trichloroethane
(TCE) in control mice (Table 4). While dietary PBB
caused elevation of LW/BW, no effects ofTCE or
TRI on LW/BW were evident. SGOT was not ele-
vated by either of these two solvents in mice con-
Environmental Health Perspectives 244suming control (0 ppm) or 100 ppm PBB diets (Table
4). Administration of 2.0 ml/kg TRI and 0.3 ml/kg
TCE proved to be lethal to mice (data not shown),
apparently due to severe depression of the central
nervous system.
Neither KW/BW nor BUN were affected by ad-
ministration of TRI or TCE in mice ingesting 0 or
100ppmPBB (Table4).
PAH SIM ratios were significantly decreased by
administration of TRI and TCE (Table 4). Statisti-
cally greater decreases, however, were evident in
tissues from mice maintained on 100 ppm PBB after
administration of 1.0 mi/kg TRI and 0.5 ml/kg TCE
(Table 4). These results suggest enhanced renal
toxicity of TRI and TCE in mice pretreated with
PBB.
The LD50 values of CHC13 and CC14 were less in
mice maintained on PBB-supplemented diets than
in control mice (Table 5). Furthermore, the CC14
LD50 was inversely proportional to the dietary con-
centration ofPBB. Thus, the lethality ofCHC13 and
CC14, as well as the renal and hepatic toxicities, was
enhancedbydietary PBB.
Table5. EffectofPBBonacuteCHC13andCCI4LD.0.a
96-hr LD50, Potency ratio
Solvent PBB, ppm mllkgb PRb.c
CHC13 0 1.00(0.87-1.14)
CHC13 100 0.39(0.35-0.43) 2.56(2.l113.05)d
CC14 0 1.84(1.55-2.18)
CC14 20 1.00(0.82-1.22) 1.84(1.46-2.32)d
CC14 100 0.28(0.25-0.31) 6.57(5.48-7.88)d
a Mice were fed diets supplemented with 0, 20, or 100 ppm
PBB for 14 (CHC13) or20(CC14) days prior to a single IP injection
ofCHC13 orCC14, incorn oil, in atotal volume of5 ml/kg. Deaths
occurring within 96 hrafter solvent administration were recorded
and LD,0 values determined by the method of Litchfield and
Wilcoxin(14).
b The 95% confidence limits are in parentheses following LD50
andPRvalues.
c Potency ratio (PR) is defined as the LD50 in mice ingesting 0
ppm PBB divided by the LD50 in mice ingesting 20 or 100 ppm
PBB.
d Significantincreaseinlethality (PR)atp <0.05.
Discussion
Results presented in this study document that
animals ingesting PBB by the dietary route are
much more susceptible to the renal and hepatic
toxicities of chlorinated hydrocarbon solvents as
well as the lethal effects ofCHC13 and CC14 than are
mice consuming control diet. Though not examined
in this study other toxic effects of solvent adminis-
trationmaybesimilarlyenhancedbydietaryPBBs.
Since PBB administration stimulates microsomal
enzyme systems in the liver (2) and the kidney (3)
(which appear to be necessary for the generation of
toxic metabolites from aliphatic chlorinated hy-
drocarbon solvents), it can be assumed that the
mechanism of PBB-induced potentiation of solvent
toxicity is stimulation ofa particular enzyme or en-
zyme pathway resulting in greater amounts oftoxic
metabolite being generated in PBB-pretreated mice
than in control mice from the same dose ofsolvent.
Thus, the mice ingesting PBBs transformed a
greater percentage of the administered dose of sol-
vent to a toxic product than did control mice. Since
renal and hepatic lesions are evident in humans as
well as other animal species following intoxication
with chlorinated hydrocarbon solvents (16), it can
be expected that PBB ingestion would similarly
"'sensitize" humans and other animal species to
solvent-induced toxicity. Furthermore, there are
several chemicals, including many carcinogens,
whose toxicity is dependent upon biotransformation
of the relatively innocuous parent compound to a
toxicant before toxic manifestations become evi-
dent. Being a potent but nonspecific inducer of the
enzymatic systems which may toxify such com-
pounds, PBBs could increase the hazard of expo-
sure ofhumans and otheranimal species to a variety
of chemicals transformed to toxicants by the vic-
tim's tissues. For example, safe chemical exposure
levels for industrial workers are determined in nor-
mal subjects, the worker ingesting PBBs may show
signs of toxicity even though the amount of toxic
chemical to which he is exposed is considered to be
within "safe" limits. Furthermore, it has been esti-
mated that 90% of human cancers are chemical in
origin (17) and that most chemical carcinogens must
be "activated" to the ultimate cancer-causing moi-
ety by in vivo metabolism (18). Thus, long-term ex-
posure to low concentrations of PBB may, by
stimulation of microsomal enzyme systems respon-
sible for toxification, "sensitize" victims to the
toxic effects of chemicals biotransformed to ulti-
matetoxicants.
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